Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 112, Issue 27, Pages 8409-8414
Publisher
Proceedings of the National Academy of Sciences
Online
2015-06-23
DOI
10.1073/pnas.1500223112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance
- (2014) J. E. Jaspers et al. CANCER RESEARCH
- Functional Genetic Approach Identifies MET, HER3, IGF1R, INSR Pathways as Determinants of Lapatinib Unresponsiveness in HER2-Positive Gastric Cancer
- (2014) Z. Zhang et al. CLINICAL CANCER RESEARCH
- Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells
- (2014) Ivo J Huijbers et al. EMBO Molecular Medicine
- An update on PARP inhibitors—moving to the adjuvant setting
- (2014) Amir Sonnenblick et al. Nature Reviews Clinical Oncology
- High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer
- (2013) F Zagouri et al. BRITISH JOURNAL OF CANCER
- Gefitinib Inhibits Invasive Phenotype and Epithelial-Mesenchymal Transition in Drug-Resistant NSCLC Cells with MET Amplification
- (2013) Silvia La Monica et al. PLoS One
- Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer
- (2013) J. F. Knight et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas
- (2012) Renê Gerhard et al. BREAST
- MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
- (2012) Sidong Huang et al. CELL
- Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches
- (2012) Martine H van Miltenburg et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors
- (2012) Janneke E. Jaspers et al. Cancer Discovery
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- Rapid validation of cancer genes in chimeras derived from established genetically engineered mouse models
- (2011) Ivo J. Huijbers et al. BIOESSAYS
- Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
- (2011) Chiara Foroni et al. CANCER TREATMENT REVIEWS
- Ensembl BioMarts: a hub for data retrieval across taxonomic space
- (2011) R. J. Kinsella et al. Database-The Journal of Biological Databases and Curation
- Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer
- (2010) So-Youn Jung et al. BREAST CANCER RESEARCH AND TREATMENT
- Safety of bevacizumab (BV) plus docetaxel (D) in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) who developed brain metastases during the AVADO phase III study.
- (2010) LY Dirix et al. CANCER RESEARCH
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- (2010) J. H. Taube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies
- (2009) Brett G. Hollier et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
- (2009) M. G. Ponzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis
- (2008) Britta Weigelt et al. BREAST CANCER RESEARCH AND TREATMENT
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started